Willem Lesterhuis

Dr

Former affiliations

The University of Western Australia

  • The University of Western Australia (M560), 35 Stirling Highway,

    6009 Perth

    Australia

  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Dr. Willem (Joost) Lesterhuis is an NHMRC RD Wright Research Fellow with the School of Biomedical Sciences and the National Centre for Asbestos Related Diseases at the University of Western Australia. He has a background as a dual-trained medical oncologist and basic researcher in tumour immunology and cancer biology.

His research focuses on identifying new effective treatment combinations in cancer, in particular in mesothelioma, and focusing on immunotherapy. Using network analysis of gene expression data from tumours in mouse models and patient samples, his research aims to identify predictive biomarkers for clinical efficacy of immuno-oncology drugs, as well as new context-specific targets for pharmacological intervention and novel combination treatments.

His research combines several lines of science; systems biology, network science, cancer biology, pharmacology/drug discovery, immunology and translational oncology.

Research interests

Current research projects include:
1- Combining chemotherapy and immunotherapy to treat cancer, in particular mesothelioma and lung cancer.
2- Unravelling the cellular and molecular processes that govern successful immunotherapy-induced cancer regression, using systems biology approaches.
3- Identification of the molecular processes that drive mesothelioma invasion using network analysis of high-dimensional molecular data from mouse models and patient samples.

Fingerprint

Dive into the research topics where Willem Lesterhuis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 11 Similar Profiles
If you made any changes in Pure these will be visible here soon.